NFC
LRMR icon

Northeast Financial Consultants’s Larimar Therapeutics LRMR Stock Holding History

Northeast Financial Consultants’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,105
Closed -$109K – 397
2021
Q4 		$109K Hold
10,105
– – 0.01% 347
2021
Q3 		$117K Buy
+10,105
New +$121K 0.01% 345
2020
Q2 		– Sell
-1,937
Closed -$18K – 301
2020
Q1 		$18K Hold
1,937
– – ﹤0.01% 270
2019
Q4 		$26K Hold
1,937
– – ﹤0.01% 304
2019
Q3 		$17K Hold
1,937
– – ﹤0.01% 322
2019
Q2 		$28K Buy
+1,937
New +$51.6K ﹤0.01% 326

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return